Biotage Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Frederic Vanderhaegen
Chief executive officer
SEK 8.3m
Total compensation
| CEO salary percentage | 20.8% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 3yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Biotage's (STO:BIOT) Dividend Will Be Increased To SEK1.65
Apr 08
Biotage AB (publ)'s (STO:BIOT) Popularity With Investors Under Threat As Stock Sinks 26%
Mar 05Is Biotage (STO:BIOT) A Risky Investment?
Feb 20
New Product Launches And Focus On High-Growth Areas Will Strengthen Future Prospects
Feb 09 Expansion in manufacturing capacity and new product launches are likely to drive revenue growth and reduce backlog.Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 48%?
Nov 16Earnings Miss: Biotage AB (publ) Missed EPS By 15% And Analysts Are Revising Their Forecasts
Oct 26Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings
Sep 17Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next
Jul 19Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?
Jun 08Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?
May 21Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | SEK 255m |
| Dec 31 2024 | SEK 8m | SEK 2m | SEK 284m |
Compensation vs Market: Frederic's total compensation ($USD855.19K) is about average for companies of similar size in the Swedish market ($USD777.28K).
Compensation vs Earnings: Insufficient data to compare Frederic's compensation with company performance.
CEO
Frederic Vanderhaegen (57 yo)
less than a year
Tenure
SEK 8,326,457
Compensation
Mr. Frederic Vanderhaegen is Chief Executive Officer & President of Biotage AB (publ) from September 16, 2024. Mr. Vanderhaegen joined the Biotage AB (publ) on September 16, 2024. Mr. Frederic was Executiv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer & President | less than a year | SEK 8.33m | no data | |
| Chief Financial Officer | 1.7yrs | no data | no data | |
| Chief Operating Officer | no data | no data | 0.010% SEK 1.1m | |
| Chief Scientific Officer | no data | no data | no data | |
| EVP of Global Marketing | no data | no data | no data | |
| Chief Human Resources & Sustainability Officer | no data | no data | 0% SEK 0 | |
| Executive Vice President of Operations | no data | no data | no data | |
| President of International - EMEA and APAC | 4.9yrs | no data | no data | |
| Executive Vice President of IT & Digitalization | no data | no data | no data | |
| Executive Vice President of Quality Assurance & Regulatory Affairs | 4.3yrs | no data | no data | |
| CEO of Cardiff Production Facility & Global Head of Environmental Working Group | no data | no data | no data |
3.0yrs
Average Tenure
52.5yo
Average Age
Experienced Management: BIOT's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 5.5yrs | SEK 14.51m | 0.40% SEK 45.3m | |
| Chairman | 2.1yrs | SEK 882.00k | no data | |
| Director | 12.1yrs | SEK 460.00k | 0.53% SEK 60.2m | |
| Director | 5.5yrs | SEK 373.00k | no data | |
| Director | 6.1yrs | SEK 320.00k | 0.00015% SEK 17.0k | |
| Director | 2.1yrs | SEK 240.00k | no data | |
| Employee Representative Director | 3.4yrs | no data | no data | |
| Director | 3.1yrs | SEK 353.00k | no data | |
| Employee Representative Director | no data | no data | no data | |
| Employee Representative Director | 1.3yrs | no data | no data |
3.4yrs
Average Tenure
61.5yo
Average Age
Experienced Board: BIOT's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/08 01:38 |
| End of Day Share Price | 2025/05/08 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotage AB (publ) is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Odysseas Manesiotis | Berenberg |
| Marcus Bellander | Carnegie Investment Bank AB |